Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers

NCT07319559 ↗

Phase 1 Completed 55 enrolled Daewon Pharmaceutical Co., Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

This study aimed to evaluate the safety and pharmacokinetic characteristics of DW5124 and DW5124-R, and the effect of food on DW5124, in healthy adult volunteers.

Timeline

Start: 2025-05-08
Primary completion: 2025-05-11
Completion: 2025-06-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	DW5124	Unknown	—	—
Subject	DW5124-R	Unknown	—	—

Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers

Summary

Timeline

Drugs

Indications